Home » Stocks » EVH

Evolent Health, Inc. (EVH)

Stock Price: $20.15 USD 0.52 (2.65%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 1.73B
Revenue (ttm) 1.02B
Net Income (ttm) -334.25M
Shares Out 84.93M
EPS (ttm) -3.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $20.15
Previous Close $19.63
Change ($) 0.52
Change (%) 2.65%
Day's Open 22.00
Day's Range 20.15 - 22.35
Day's Volume 1,653,307
52-Week Range 3.50 - 22.35

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 2 days ago

The company released its quarterly update after the market closed on Thursday, and investors like what they saw.

PRNewsWire - 3 days ago

WASHINGTON, Feb. 25, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today anno...

PRNewsWire - 5 days ago

WASHINGTON, Feb. 23, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers...

PRNewsWire - 1 month ago

WASHINGTON, Jan. 13, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (the "Company" or "Evolent"), a health care company that delivers proven clinical and administrative solutions to pay...

PRNewsWire - 2 months ago

WASHINGTON, Dec. 22, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (the "Company" or "Evolent"), a health care company that delivers proven clinical and administrative solutions to pay...

PRNewsWire - 3 months ago

WASHINGTON, Nov. 23, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers...

Seeking Alpha - 3 months ago

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q3 2020 Results - Earnings Call Transcript

Business Wire - 3 months ago

CHICAGO--(BUSINESS WIRE)-- #maskup--Evolent Health, which supports over 375,000 Cook County Medicaid beneficiaries, is donating 10,000 face masks to community organizations on Nov. 9.

Zacks Investment Research - 3 months ago

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 4 months ago

WASHINGTON, Oct. 22, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today anno...

PRNewsWire - 5 months ago

WASHINGTON, Sept. 21, 2020 /PRNewswire/ -- Evolent Health (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced...

PRNewsWire - 5 months ago

WASHINGTON, Sept. 9, 2020 /PRNewswire/ -- Evolent Health, Inc.

The Motley Fool - 6 months ago

A refinancing gone wrong?

Seeking Alpha - 6 months ago

Evolent Health, Inc. (EVH) CEO Frank Williams on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Evolent Health (EVH) delivered earnings and revenue surprises of 70.00% and -1.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 6 months ago

WASHINGTON, July 31, 2020 /PRNewswire/ -- Done right, remote health advising and other care management interventions can significantly reduce hospitalizations and medical spend for high-risk M...

Zacks Investment Research - 7 months ago

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Investors Business Daily - 7 months ago

Evolent Health sees its Relative Strength Rating hit the elite 90-plus level. The post Stocks Showing Market Leadership: Evolent Health Earns 90 RS Rating appeared first on Investor's Business...

The Motley Fool - 7 months ago

The company is making lemonade out of the lemons that Kentucky's Medicaid program handed it.

PRNewsWire - 7 months ago

WASHINGTON, July 17, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today anno...

PRNewsWire - 7 months ago

WASHINGTON, July 13, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, has been n...

Newsfile Corp - 8 months ago

New York, New York--(Newsfile Corp. - June 25, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolent Health, Inc. (NYSE: EVH)...

Newsfile Corp - 8 months ago

New York, New York--(Newsfile Corp. - June 23, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolent Health, Inc. (NYSE: EVH)...

PRNewsWire - 8 months ago

NEW YORK, June 8, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolent Health, Inc. ("Evolent" o...

Zacks Investment Research - 8 months ago

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

The Motley Fool - 8 months ago

The healthcare administration company may lose a major partner.

Benzinga - 8 months ago

Evolent Health (NYSE: EVH) shares are trading lower on Monday. The company announced its partner, Passport Health Plan, was not selected for Kentucky managed Medicaid contract.

Seeking Alpha - 9 months ago

Evolent Health, Inc. (EVH) CEO Frank Williams on Q1 2020 Results - Earnings Call Transcript

The Motley Fool - 9 months ago

This healthcare company appears to be pretty healthy.

Seeking Alpha - 1 year ago

Evolent Health's (EVH) CEO Frank Williams on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Evolent Health (EVH) delivered earnings and revenue surprises of -75.00% and 1.47%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

The Motley Fool - 1 year ago

Some stocks took a pre-holiday hit.

Other stocks mentioned: CENT, DAKT
The Motley Fool - 1 year ago

A major contract loss in Kentucky is weighing heavily on the managed-care stock.

Zacks Investment Research - 1 year ago

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

The Motley Fool - 1 year ago

The health information services company is optimistic about 2020.

Seeking Alpha - 1 year ago

Evolent Health's (EVH) CEO Frank Williams on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Evolent Health (EVH) delivered earnings and revenue surprises of 40.00% and 1.31%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

24/7 Wall Street - 1 year ago

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: ECA, FLMN, SIEN, VSLR
Seeking Alpha - 1 year ago

Evolent Health, Inc. (EVH) CEO Frank Williams on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 1 year ago

Though it's no small task, here are two companies that are trying to change the way Americans think about their healthcare.

Other stocks mentioned: TDOC
24/7 Wall Street - 1 year ago

While Most of Wall Street focuses on large- and mega-cap stocks because they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: ADT, AR, KOS, VSLR
GuruFocus - 1 year ago

Axogen, Evolent Health present appealing opportunities.

Other stocks mentioned: AXGN
The Motley Fool - 1 year ago

Find out why these stocks stood out in a down market.

Other stocks mentioned: CAMP, GIS
The Motley Fool - 1 year ago

Shares nose-dive after the company announces a surprise acquisition. Here's what investors need to know.

Seeking Alpha - 1 year ago

Evolent Health, Inc. (EVH) CEO Frank Williams on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Evolent Health (EVH) delivered earnings and revenue surprises of 8.82% and 2.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

About EVH

Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management sol... [Read more...]

Industry
Health Information Services
IPO Date
Jun 5, 2015
CEO
Frank Williams
Country
United States
Stock Exchange
NYSE
Ticker Symbol
EVH
Full Company Profile

Financial Performance

In 2020, Evolent Health's revenue was $1.02 billion, an increase of 20.80% compared to the previous year's $846.38 million. Losses were -$334.25 million, 10.7% more than in 2019.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for Evolent Health stock is "Buy." The 12-month stock price forecast is 18.71, which is a decrease of -7.15% from the latest price.

Price Target
$18.71
(-7.15% downside)
Analyst Consensus: Buy